Anti–cytotoxic T-lymphocyte–associated antigen-4 monoclonal antibody quavonlimab in combination with pembrolizumab: Safety and efficacy from a phase I study in previously treated extensive-stage small cell lung cancer

Byoung Chul Cho, Kiyotaka Yoh, Ruth Perets, Adnan Nagrial, David R. Spigel, Martin Gutierrez, Dong Wan Kim, Dusan Kotasek, Drew Rasco, Jiaxin Niu, Miyako Satouchi, Myung Ju Ahn, Dae Ho Lee, Corinne Maurice-Dror, Shabana Siddiqi, Yixin Ren, Rachel A. Altura, Jair Bar

Research output: Contribution to journal › Article › peer-review

5 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Anti–cytotoxic T-lymphocyte–associated antigen-4 monoclonal antibody quavonlimab in combination with pembrolizumab: Safety and efficacy from a phase I study in previously treated extensive-stage small cell lung cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science